• SENSEX 76,738.17
    585.31 (+0.77%)
  • BANKNIFTY 57,380.60
    208.60 (+0.36%)
  • Gland Pharma
    2,826.60 1,575.00(%)
  • Tata Technolog.
    830.10 890.15(%)
  • IFCI
    103.95 101.60(%)
  • HFCL
    231.40 257.00(%)
  • Lumino Inds
    122.00 119.00(%)
  • Jindal Worldwide
    57.06 47.55(%)
  • Netweb Technol.
    5,424.00 5,810.00(%)
  • Angel One
    308.20 360.20(%)
  • HBL Engineering
    723.85 1,121.95(%)
  • Multi Comm. Exc.
    3,257.00 3,479.80(%)
  • Adani Total Gas
    620.85 859.70(%)
  • Lenskart Solut.
    694.75 680.95(%)
  • Oberoi Realty
    1,932.25 1,985.00(%)
  • RBL Bank
    413.50 410.45(%)
  • Tejas Networks
    613.50 644.75(%)
  • Polycab India
    8,308.55 6,660.50(%)
  • Antelopus Selan
    986.05 357.00(%)
  • Nuvoco Vistas
    353.50 477.35(%)
  • One 97
    1,691.50 1,732.00(%)
  • Reliance Industries
    1,332.30 1,611.20(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Bajaj Healthcare Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 67906.0
  • ISIN : INE411U01027
325.20 -4 (-1.16%)
  • As on 04 Sep 2026 (EOD)
  • Today’s Low

    324.60
  • Today’s High

    339.90
  • Open

    330.00
  • Perv Close

    329.00
  • 52W Low

    272.35
  • 52W High

    515.90

Key Indicators

  • P/E(TTM)

    19.55

  • Mar.Cap (₹Cr.)

    1,094.71

  • Div & Yield %

    0.46

  • Book Value(₹)

    158.34

  • Debt-Equity Ratio

    -1.16

  • AGM Date

    03-Sep-2026

  • EPS

    16.72

  • P/E Ratio

    19.55

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    1,094.71

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    16.83

  • BV (₹)

    158.30

  • Sales( ₹ in Cr.)

    611.03

  • NP (in Cr.)

    46.94

  • NP Var(%)

    18.0

  • Div%

    30.0

  • CPS (₹)

    22.10

  • EPS (₹)

    13.90

  • Traded Value (₹ in Lakhs)

    1,100.60

  • 52 Week High

    515.90

  • 52 Week Low

    272.35

  • Price BSE

    327.0

  • Price NSE

    325.00

  • Market Capital( in Cr.)

    1,100.60

  • P/C Ratio

    14.80

  • P/E Ratio

    23.40

  • Price Vs.BV

    13.90

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar
INCOME :            
Sales Turnover 542.60 473.42 645.80 679.89 656.98 410.01
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 542.60 473.42 645.80 679.89 656.98 410.01
Other Income 19.40 8.69 1.59 1.44 6.91 6.53
Stock Adjustments 20.66 9.66 11.06 3.77 -0.70 5.09
Total Income 582.66 491.77 658.45 685.10 663.19 421.63
EXPENDITURE :            
Raw Materials 307.11 264.43 393.84 409.91 377.19 268.32
Power and Fuel Cost 22.77 31.47 37.69 31.83 24.96 24.24
Employee Cost 57.06 43.85 42.32 41.11 34.55 28.18
Other Manufacturing Expenses 69.15 42.11 44.46 61.48 66.31 29.79
Selling and Administration Expenses 18.55 16.21 14.86 14.86 12.91 8.00
Miscellaneous Expenses 9.48 122.47 32.71 5.81 4.00 8.28
Employee Benefit Expenses 57.06 43.85 42.32 41.11 34.55 28.18
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 484.12 520.54 565.88 565.00 519.91 366.81
Operating Profit 98.55 -28.77 92.56 120.10 143.28 54.81
Interest 28.06 29.75 17.68 12.78 8.34 6.63
Gross Profit 70.49 -58.52 74.88 107.32 134.94 48.18
Depreciation 27.92 27.62 17.21 17.64 16.12 12.12
Profit Before Tax 42.57 -86.14 57.67 89.68 118.82 36.06
Current Tax 0.00 1.36 16.36 18.91 35.21 9.33
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 3.08 -3.71 -1.71 -0.61 0.50 1.49
Reported Net Profit 39.50 -83.79 43.02 71.39 83.11 25.24
Extraordinary Items -0.31 -44.29 0.00 0.00 0.01 0.02
Adjusted Net Profit 39.81 -39.50 43.02 71.39 83.10 25.22
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 -0.20
P & L Balance brought forward 267.38 353.93 315.05 245.04 164.35 139.31
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 2.76 2.76 4.14 1.38 2.41 0.00
P & L Balance carried down 304.12 267.38 353.93 315.05 245.04 164.35
Dividend 2.76 2.76 4.14 1.38 2.41 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 20.00 20.00 20.00 30.00 27.50 0.00
Dividend Per Share(Rs) 1.00 1.00 1.00 1.50 2.75 0.00
Earnings Per Share-Unit Curr 12.51 -30.36 15.59 25.87 60.23 18.29
Earnings Per Share(Adj)-Unit Curr 12.51 -30.36 15.59 25.87 30.12 9.15
Book Value 142.04 100.86 133.23 119.02 187.26 128.94
Book Value(Adj)-Unit Curr 142.04 100.86 133.23 119.02 93.63 64.47

Shareholding Pattern

  • Promoter Group

    58.59%

  • Public Share Holding

    41.41%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 300,000 0.89 300,000 2
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 19,422,885 57.70 19,422,885 6
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 19,722,885 58.59 19,722,885 8
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 736,818 2.19 736,818 12
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 569,411 1.69 569,411 3
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 78,000 0.23 78,000 1
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 1,384,229 4.11 1,384,229 16
2] Non Institution
Bodies Corporate 1,236,471 3.67 1,236,471 206
Clearing Members 61,658 0.18 61,658 18
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 476,271 1.41 476,271 686
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 486,377 1.44 486,377 727
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 2,419,462 7.19 2,419,462 19
Individuals holding nominal share capital up to Rs. 1 lakh 7,616,601 22.63 7,616,601 39,597
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 5,400 0.02 5,400 2
Others 0 0.00 0 0
Sub Total 12,555,547 37.30 12,555,547 41,286
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 33,662,661 100.00 33,662,661 41,310

Company Background

Bajaj Healthcare LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Bajaj Healthcare Ltd
  • BSE Code : 67906.0
  • ISIN : INE411U01027
  • Incorporation Year

    1993

  • Registered Office

    602-606 Bhoomi Velocity Infote
    Road No 23 Wagle Indl Estate, Thane,
    Maharashtra-400604

  • Telephone

    91-22-66177400/401

  • FAX

    91-22-66177458

  • Chairman

    Sanjankumar R Bajaj

  • Managing Director

    Sanjankumar R Bajaj

  • Company Secretary

    Monica Tanwar

  • Auditor

    Walker Chandiok & Co LLP

  • Face Value

    5

  • Listing

    NSE

  • Registrar

    Sharex Dynamic (India) Pvt Ltd
    Unit No 1 Luthra Ind,
    Andheri Kurla Road ,Safed Pool Andheri(E
    Mumbai - Mumbai - 400 072

Bajaj Healthcare Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Bajaj Healthcare 326.95 562.01 542.60 62.40 10.27
Abbott India 25,878.50 7,217.19 6,929.05 34.06 43.78
Astrazeneca Phar 6,946.95 2,304.07 2,275.58 102.39 27.86
Glaxosmi. Pharma 2,935.35 3,932.76 3,790.20 46.89 58.17
Novartis India 1,614.95 398.23 356.27 40.78 16.64
Cipla 1,389.00 20,102.60 18,979.95 36.50 13.88
Bliss GVS Pharma 636.90 773.53 729.81 59.14 12.51
Amrutanjan Healt 507.20 520.13 502.55 27.17 24.16
Fermenta Biotec. 502.80 474.15 450.25 23.47 18.77
Guj. Themis Bio. 425.00 152.47 150.80 113.64 27.21
Ambalal Sarabhai 43.88 19.52 3.94 81.26 6.77